메뉴 건너뛰기




Volumn 37, Issue 5, 2009, Pages 235-241

Psoriasis

Author keywords

CoPSI; DLQI; K bner phenomenon; PASI; psoriasis

Indexed keywords

ADALIMUMAB; CALCINEURIN INHIBITOR; CALCIPOTRIOL; CHLOROQUINE; COAL TAR; CORTICOSTEROID; CYCLOSPORIN A; DITHRANOL; EMOLLIENT AGENT; ETANERCEPT; ETRETIN; FUMARIC ACID; HYDROXYUREA; INFLIXIMAB; LITHIUM; METHOTREXATE; PIMECROLIMUS; PSORALEN; RETINOID DERIVATIVE; SALICYLIC ACID; SULFUR; TACALCITOL; TACROLIMUS; TAR; TAZAROTENE; TOPICAL AGENT; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNINDEXED DRUG; USTEKINUMAB; VITAMIN D DERIVATIVE;

EID: 65549166281     PISSN: 13573039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpmed.2009.02.005     Document Type: Review
Times cited : (4)

References (2)
  • 2
    • 47549092935 scopus 로고    scopus 로고
    • A study examining inter- and intra-rater reliability of a novel instrument for assessment of psoriasis: The Copenhagen psoriasis severity index (CoPSI)
    • Berth-Jones J., Thompson J., and Papp K. A study examining inter- and intra-rater reliability of a novel instrument for assessment of psoriasis: The Copenhagen psoriasis severity index (CoPSI). Br J Dermatol 159 (2008) 407-412
    • (2008) Br J Dermatol , vol.159 , pp. 407-412
    • Berth-Jones, J.1    Thompson, J.2    Papp, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.